X. V. Wijk

Heparan sulfate in angiogenesis: a target for therapy

T. H. Kuppevelt, X. V. Wijk, T. Kuppevelt, 2013, Angiogenesis.

A common sugar‐nucleotide‐mediated mechanism of inhibition of (glycosamino)glycan biosynthesis, as evidenced by 6F‐GalNAc (Ac3)

A. Griffioen, D. Lefeber, Natasha Naidu, 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Heparan sulfate in angiogenesis: a target for therapy

T. H. Kuppevelt, X. V. Wijk, T. Kuppevelt, 2013, Angiogenesis.

Chemical biology of heparan sulfate : development of tools, and use of sugar analogs to inhibit heparan sulfate biosynthesis and angiogenesis

X. V. Wijk, X. Wijk, 2013 .

Pharmacogenomic‐Based Decision Support to Predict Adherence to Medications

Brittany A. Borden, M. Ratain, P. O’Donnell, 2020, Clinical pharmacology and therapeutics.

Full Title: Role of von Willebrand Factor in COVID-19 Associated Coagulopathy Running Head: Role of vWF in CAC

Maximo J Marin, H. Pham, X. V. Wijk, 2021 .